EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allergen-specific sublingual immunotherapy altered gut microbiota in patients with allergic rhinitis

Jing Wu, Dan Wang, Wen-Jun He, Jun-Yang Li, Xi Mo, You-Jin Li

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1454333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Jing Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Hainan Branch, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Sanya, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Sublingual Immunotherapy, Rhinitis, Allergic, Feces. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Allergen-specific immunotherapy (AIT) induces long-term immune tolerance to allergens and is effective for treating allergic rhinitis (AR). However, the impact of sublingual immunotherapy (SLIT) on gut microbiota from AR patients and its correlation with treatment efficacy remains unclear.

Methods

In the present study, we enrolled 24 AR patients sensitized to Dermatophagoides farinae (Der-f) and 6 healthy donors (HD). All AR patients received SLIT treatment using standardized Der-f drops. Stool samples were collected from AR patients before treatment, and 1- and 3-months post-treatment, as well as from HD, for metagenomic sequencing analysis.

Results

AR patients had significantly lower richness and diversity in gut microbiota compared to HD, with notable alterations in composition and function. Besides, three months post-SLIT treatment, significant changes in gut microbiota composition at the genus and species levels were observed in AR patients. Streptococcus parasanguinis_B and Streptococcus parasanguinis , which were significantly lower in AR patients compared to HD, increased notably after three months of treatment. LEfSe analysis identified these species as markers distinguishing HD from AR patients and AR patients pre- from post-SLIT treatment. Furthermore, changes in the relative abundance of S. parasanguinis_B were negatively correlated with changes in VAS scores but positively correlated with changes in RCAT scores, suggesting a positive correlation with effective SLIT treatment.

Discussion

SLIT treatment significantly alters the gut microbiota of AR patients, with S. parasanguinis_B potentially linked to its effectiveness. This study offers insights into SLIT mechanisms and suggests that specific strains may serve as biomarkers for predicting SLIT efficacy and as modulators for improving SLIT efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeSublingual ImmunotherapyRhinitis, AllergicFecesHumansMaleFemaleAdultAllergensYoung AdultAnimalsMiddle AgedAntigens, DermatophagoidesDermatophagoides farinaeTreatment OutcomeAdolescentMetagenomics

Stichwörter der Autor:innen

Streptococcus parasanguinis_Ballergen-specific sublingual immunotherapyallergic rhinitisdermatophagoides farinaegut microbiota

Substanzen

AllergensAntigens, Dermatophagoides

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Hainan Branch, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Sanya, China.
  • Central Lab, Hainan Branch, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Sanya, China.
  • Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Science and Education, Hainan Branch, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Sanya, China.
  • Department of Otolaryngology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Zitieren

APA

Wu, J., Wang, D., He, W. J., Li, J. Y., Mo, X., & Li, Y. J. (2024). Allergen-specific sublingual immunotherapy altered gut microbiota in patients with allergic rhinitis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1454333

Vancouver

Wu J, Wang D, He WJ, Li JY, Mo X, Li YJ. Allergen-specific sublingual immunotherapy altered gut microbiota in patients with allergic rhinitis. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1454333

BibTeX
@article{Wu2024,
  author = {Wu, Jing and Wang, Dan and He, Wen-Jun and Li, Jun-Yang and Mo, Xi and Li, You-Jin},
  title = {Allergen-specific sublingual immunotherapy altered gut microbiota in patients with allergic rhinitis},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1454333}
}
Kostenlos starten →